177 related articles for article (PubMed ID: 38386050)
21. Liver Transplant for Intrahepatic Cholangiocarcinoma.
Eletta OA; Panayotova GG; Lunsford KE
Surg Clin North Am; 2024 Feb; 104(1):215-225. PubMed ID: 37953037
[TBL] [Abstract][Full Text] [Related]
22. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation.
Maganty K; Levi D; Moon J; Bejarano PA; Arosemena L; Tzakis A; Martin P
Dig Dis Sci; 2010 Dec; 55(12):3597-601. PubMed ID: 20848202
[TBL] [Abstract][Full Text] [Related]
23. Liver Transplant for Cholangiocarcinoma.
Zamora-Valdes D; Heimbach JK
Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
[TBL] [Abstract][Full Text] [Related]
24. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
25. Incidental intrahepatic cholangiocarcinoma in patients undergoing liver transplantation: A multi-center study in Japan.
Hara T; Eguchi S; Yoshizumi T; Akamatsu N; Kaido T; Hamada T; Takamura H; Shimamura T; Umeda Y; Shinoda M; Ogura Y; Fukumoto T; Kasahara M; Hibi T; Umeshita K; Furukawa H; Ohdan H
J Hepatobiliary Pancreat Sci; 2021 Apr; 28(4):346-352. PubMed ID: 33464720
[TBL] [Abstract][Full Text] [Related]
26. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
Dong L; Lu D; Chen R; Lin Y; Zhu H; Zhang Z; Cai S; Cui P; Song G; Rao D; Yi X; Wu Y; Song N; Liu F; Zou Y; Zhang S; Zhang X; Wang X; Qiu S; Zhou J; Wang S; Zhang X; Shi Y; Figeys D; Ding L; Wang P; Zhang B; Rodriguez H; Gao Q; Gao D; Zhou H; Fan J
Cancer Cell; 2022 Jan; 40(1):70-87.e15. PubMed ID: 34971568
[TBL] [Abstract][Full Text] [Related]
27. circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma.
Xu YP; Dong ZN; Wang SW; Zheng YM; Zhang C; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Peng R; Tang MC; Bai DS; Huang XY; Guo CY
J Exp Clin Cancer Res; 2021 Sep; 40(1):290. PubMed ID: 34526098
[TBL] [Abstract][Full Text] [Related]
28. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
29. Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.
Panayotova GG; Paterno F; Guarrera JV; Lunsford KE
Curr Oncol Rep; 2020 Apr; 22(5):49. PubMed ID: 32297105
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
Hong JC; Jones CM; Duffy JP; Petrowsky H; Farmer DG; French S; Finn R; Durazo FA; Saab S; Tong MJ; Hiatt JR; Busuttil RW
Arch Surg; 2011 Jun; 146(6):683-9. PubMed ID: 21690444
[TBL] [Abstract][Full Text] [Related]
31. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
32. Liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?
Kodali S; Saharia A; Ghobrial RM
Curr Opin Organ Transplant; 2022 Aug; 27(4):320-328. PubMed ID: 36354258
[TBL] [Abstract][Full Text] [Related]
33. Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
Xu YP; Dong ZN; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Huang XY; Guo CY
Dig Dis Sci; 2022 Feb; 67(2):559-568. PubMed ID: 33576946
[TBL] [Abstract][Full Text] [Related]
34. LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.
Gu S; Chen J; Zhou Q; Yan M; He J; Han X; Qiu Y
Dig Dis Sci; 2020 Feb; 65(2):500-508. PubMed ID: 31489563
[TBL] [Abstract][Full Text] [Related]
35. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
36. KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression.
Tanaka M; Kunita A; Yamagishi M; Katoh H; Ishikawa S; Yamamoto H; Abe J; Arita J; Hasegawa K; Shibata T; Ushiku T
Liver Int; 2022 Oct; 42(10):2329-2340. PubMed ID: 35833881
[TBL] [Abstract][Full Text] [Related]
37. 10-year tumor-free survival after intraoperative radiation therapy and secondary liver transplantation for hilar cholangiocarcinoma.
Sotiropoulos GC; Lang H; Niebel W; Malago M; Broelsch CE
Transplantation; 2004 May; 77(10):1625. PubMed ID: 15239635
[No Abstract] [Full Text] [Related]
38. Long-term tumor-free survival after liver transplantation for the treatment of hilar cholangiocarcinoma: A case report.
Huang XH; Jiang Y; Lv LZ; Hu HZ
Asian J Surg; 2021 Aug; 44(8):1081-1082. PubMed ID: 34049790
[No Abstract] [Full Text] [Related]
39. PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA.
Ernani L; Martino RB; Andraus W; Fernandes ESM; Mello FPT; Andrade R; Pimentel LS; Haddad LBP; Coelho FF; Herman P; D'Albuquerque LAC
Arq Bras Cir Dig; 2022; 34(3):e1618. PubMed ID: 35019130
[TBL] [Abstract][Full Text] [Related]
40. Intrahepatic cholangiocarcinoma: indication for transplantation.
Pascher A; Jonas S; Neuhaus P
J Hepatobiliary Pancreat Surg; 2003; 10(4):282-7. PubMed ID: 14598146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
